Hetero, Cipla get gesture to make, market antiviral medication remdesivir Kumar Jeetendra | June 21, 2020 India’s Drug Regulator on June 20 allowed to Hetero and Cipla to produce and market antiviral medication remdesivir for “confined crisis use” on hospitalized COVID-19 patients, official sources said. This comes a day after the Drug Controller General of India (DCGI), thinking about the crisis and neglected requirement for medications considering the coronavirus episode, allowed …
MMR immunization could offer assurance against COVID-19 Kumar Jeetendra | June 20, 2020 Directing the MMR (measles, mumps, rubella) antibody could fill in as a preventive measure to hose septic aggravation related with COVID-19 disease, state a group of specialists in the current week’s mBio, a diary of the American Society for Microbiology. Long-term colleagues and life partners Dr. Paul Fidel, Jr., Department Chair, Oral and Craniofacial Biology, …
DCGI supports Restricted Use of Anti-viral Drug Favipiravir for Coronavirus Patients Kumar Jeetendra | June 20, 2020 The Drug Controller General of India (DCGI) has affirmed the utilization of hostile to viral medication Favipiravir for COVID-19 patients for confined use. The medication can be utilized distinctly if there should be an occurrence of a crisis and family assent of the patient is obligatory. The term of the course is 14 days. Glenmark …
Immunotherapy – Evolving cancer care during COVID 19 pandemic Kumar Jeetendra | June 19, 2020 The COVID 19 pandemic has touched every aspect of human life including healthcare delivery for other chronic diseases. With the explosion of medical information on this pandemic, medical care for diseases like cancer is also evolving every day. Gone are the days when patients used to schedule day care chemotherapy appointments like any other regular …
Polio immunization for COVID-19 ‘testable’, may offer constrained security: Scientists Kumar Jeetendra | June 19, 2020 Indian researchers have reacted mindfully to a proposal by worldwide specialists that the oral polio antibody be tried for COVID-19, saying it is a “testable thought” in view of a sound logical idea however may offer just restricted security against the contamination. With an immunization for COVID-19 in any event a year away, researchers state …
Researchers unravel how the brain detects smell Kumar Jeetendra | June 19, 2020 Researchers have additionally decoded how mammalian cerebrums see scents and recognize one smell from a great many others. In tests in mice, NYU Grossman School of Medicine specialists have just because made an electrical mark that is seen as a scent in the cerebrum’s smell-preparing focus, the olfactory bulb, despite the fact that the smell …
Israel consents to arrangement with Moderna for potential COVID-19 antibody Kumar Jeetendra | June 18, 2020 Israel has consented to an arrangement with Moderna Inc for the future acquisition of its potential COVID-19 antibody, Prime Minister Benjamin Netanyahu said on Wednesday. The Cambridge, Massachusetts-based biotech firm a week ago affirmed intends to begin a preliminary of 30,000 volunteers of its eagerly awaited immunization in July as the organization enters the last …
WHO ends preliminary of hydroxychloroquine in COVID-19 patients Kumar Jeetendra | June 18, 2020 The World Health Organization said that testing of the intestinal sickness tranquilize hydroxychloroquine in its enormous multi-nation preliminary of medicines for COVID-19 patients had been stopped after outcomes from different preliminaries demonstrated no advantage. “The hydroxychloroquine arm of the SOLIDARITY preliminary has been halted,” WHO master Ana Maria Henao-Restrepo told a news instructions.
New Range of SARS-CoV-2 Spike Protein Products Kumar Jeetendra | June 17, 2020 AMSBIO has launched a range of ready-to-use SARS-CoV-2 Spike protein coupled magnetic beads that combine convenience, minimum non-specific binding and developed operational protocols saving you time and hassle. Developed for immunocapture, cell stimulating, biopanning and flow cytometry applications these new products use biotinylated SARS-CoV-2 Spike protein pre-coupled to streptavidin conjugated magnetic beads, which can capture …
Serum Institute of India, UNICEF flexibly consent to give pneumonia immunization to low-income countries Kumar Jeetendra | June 17, 2020 The Serum Institute of India will give ten million portions of the pneumococcal conjugate immunization, which assists with forestalling serious pneumonia, consistently to bring down salary nations for the following decade under another gracefully concurrence with the UNICEF that helped significantly diminished the cost of pneumonia antibody for those countries. “Pneumonia is the greatest single …
WHO sees ‘incredible news’ in steroid’s preliminary outcomes in COVID-19 Kumar Jeetendra | June 17, 2020 The World Health Organization (WHO) hailed as “incredible news” introductory clinical preliminary outcomes that demonstrated a modest and generally utilized steroid called dexamethasone can help spare the lives of fundamentally sick COVID-19 patients. “This is the primary treatment to be appeared to decrease mortality in patients with COVID-19 requiring oxygen or ventilator support,” WHO Director-General …
“TOTAL ANTIBODY DETECTION ASSAY KIT” for COVID -19 launched in India by J.Mitra Kumar Jeetendra | June 17, 2020 New Delhi, 17th June 2020: J Mitra & Co. Pvt Ltd, India’s leading global MNC in the In-Vitro Diagnostics (IVD) industry has launched its state-of-the-art Covid-19 Test Kit in the Indian market. Based on the Double Sandwich Elisa technology, the test kit is known as COVID-19 [IgM, IgG, IgA] MICROLISA. It is a serology-based total …
